Hyaluronan modulates cell proliferation and mRNA expression of adhesion-related procollagens and cytokines in glenohumeral synovial/capsular fibroblasts in adhesive capsulitis.
There is a growing body of evidence supporting the use of hyaluronan (HA) in patients with adhesive capsulitis of the shoulder, although the mechanisms of the effect have not yet been clarified. This in vitro study examined the effects of HA on glenohumeral synovial/capsular fibroblasts (GSCFs) from patients with adhesive capsulitis of the shoulder. The study subjects were seven patients with primary or secondary adhesive capsulitis of the shoulder (average age: 55 years; range: 42-65). Synovial/capsular specimens were obtained from the rotator interval of each patient during arthroscopy. Part of the tissue specimen was used for histological analysis. The remainder of the tissue was prepared for cell culture. Various concentrations of HA (0.0-4.0 mg/mL) were added to the monolayer-cultured GSCFs from these patients. Histological analysis consistently demonstrated chronic nonspecific inflammation with synovial hyperplasia, proliferation of vessels and fibroblasts, and increased amount of extracellular matrix. Treatment with HA at various concentrations significantly and dose-dependently inhibited cell proliferation and decreased the expression levels of mRNA for adhesion-related procollagens and cytokines. Pretreatment with OS/37 did not reverse the inhibitory effect of HA. These results suggest that HA modulates cell proliferation and expression of the mRNA of adhesion-related procollagens and cytokines in GSCFs, preventing the progression of adhesion formation in patients with adhesive capsulitis of the shoulder.
Nago
Masaru
M
Department of Orthopedic Surgery, Kurume University, Kurume, Fukuoka, Japan.
Mitsui
Yasuhiro
Y
Gotoh
Masafumi
M
Nakama
Kenjirou
K
Shirachi
Isao
I
Higuchi
Fujio
F
Nagata
Kensei
K
D000328:Adult; D000368:Aged; D002062:Bursitis / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D016207:Cytokines / Q000235:genetics*; D005260:Female; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D006811:Humerus / Q000378:metabolism / Q000473:pathology*; D006820:Hyaluronic Acid / Q000494:pharmacology*; D017746:Joint Capsule / Q000378:metabolism / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011347:Procollagen / Q000235:genetics*; D012333:RNA, Messenger / Q000032:analysis*
D016207:Cytokines; D011347:Procollagen; D012333:RNA, Messenger; D006820:Hyaluronic Acid